Generation Investment Management Reduces $227M in Synopsys, Inc. ($SNPS)
Key Points
- Generation Investment Management changed its Synopsys, Inc. ($SNPS) stake by 100.0% last quarter, cutting to 0 shares.
- Wall Street's consensus rating on $SNPS is Buy and an average price target of $560.38.
- $SNPS last traded around $453.89.
Generation Investment Management reduced its position in Synopsys, Inc. ($SNPS), according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 0 shares of Synopsys, Inc. after selling 499,931 shares during the quarter.
Synopsys, Inc. ($SNPS) Stock
Synopsys, Inc. Earnings
Analysts Set New Price Targets
About Synopsys, Inc.
Synopsys, Inc. provides design IP solutions in the semiconductor and electronics industries. It operates in two segments, Design Automation and Design IP. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; FPGA design products that are programmed to perform specific functions; synopsys technology computer-aided design (TCAD), mask synthesis, and manufacturing analytic solutions; and AI-driven EDA solutions. It also provides pre-verified and silicon-proven IP solutions, logic libraries and embedded memories, processor and security solutions, IP Offerings for the automotive market, SOC infrastructure IP, data path and building block IP, and mathematical and floating-point components. Synopsys, Inc. has a strategic collaboration with Arm Holdings plc for development of AGI CPU that provides solutions across its full-stack design portfolio including EDA, interface IP, and hardware-assisted verification (HAV). The company was incorporated in 1986 and is headquartered in Sunnyvale, California.
See Also
This instant news alert was generated by automated narrative technology and financial data from Trueearnings and public regulatory filings. It is for informational purposes only and is not financial advice.